Read the second message in a series from NCATS Director Joni Rutter on approaches NCATS has used to build more accurate models for drug discovery and development.

Learn More

Scientists Build Ferroptosis Inhibitors to Curb Cell Death Process Linked to Alzheimer’s Disease and Cancer

Researchers at the University of Pittsburgh, the University of Toruń in Poland, NCATS and other institutions worked together to design, build and test two new ferroptosis inhibitors.

Read More

Can Metformin Treat COVID-19 and Prevent Long COVID? NCATS and Partners Pursue Answers

NCATS helped researchers explore metformin as a treatment for COVID-19, from early observational studies all the way to the ACTIV-6 clinical trial.

Read More

N3C Data Help Validate Two Clinical Tools to Predict COVID-19 Mortality Risk

Two new COVID-19 risk-prediction tools tested in part using the NCATS National COVID Cohort Collaborative (N3C) could help clinicians make faster and better treatment decisions.

Read More

Early Newborn Screening Boosts Survival in Rare Immune Disorders

An NCATS-led Rare Diseases Clinical Research Network consortium developed lifesaving therapies for SCID and pioneered a screening test for newborns.

Read More

Check Out Our New Website

The website features new resource pages for researchers, trainees, and our rare diseases community, plus handy filters to find research activities, funding opportunities, news and events.

Read More

Learn more about these and other staff members >